David Spirk Selected Research

David Spirk Research Topics

7	Myocardial Infarction 03/2024 - 08/2009
7	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 06/2014
6	Pathologic Constriction (Stenosis) 03/2024 - 06/2014
6	Thrombosis (Thrombus) 11/2023 - 01/2015
6	Hemorrhage 10/2023 - 08/2009
6	Neoplasms (Cancer) 05/2021 - 10/2009
5	Infarction (Infarctions) 03/2024 - 01/2021
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 01/2021
4	Venous Thromboembolism 10/2022 - 01/2016
4	Hypertension (High Blood Pressure) 01/2020 - 01/2012
3	Pulmonary Embolism 03/2024 - 04/2012
3	Atherosclerotic Plaque (Atheroma) 10/2023 - 01/2021
3	COVID-19 10/2023 - 08/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 04/2017
2	Acute Coronary Syndrome 01/2021 - 01/2016
2	May-Thurner Syndrome 12/2019 - 07/2019
2	Lung Diseases (Lung Disease) 01/2016 - 04/2012
2	Heart Failure 01/2016 - 04/2012
1	Disease Progression 03/2024
1	Venous Insufficiency 03/2024
1	Ulcer 03/2024
1	Pain (Aches) 03/2024
1	Peripheral Arterial Disease 11/2022
1	Rupture 10/2022
1	Thrombophlebitis 05/2022
1	Hypercholesterolemia 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Postthrombotic Syndrome 12/2019
1	Embolism (Embolus) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Stroke (Strokes) 01/2016
1	Atrial Fibrillation 01/2016
1	Weight Gain 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Wounds and Injuries (Trauma) 10/2009

7	alirocumabIBA 03/2024 - 01/2021
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 01/2021
4	Enoxaparin (Lovenox)FDA LinkGeneric 10/2023 - 08/2009
3	LipidsIBA 10/2023 - 01/2021
3	RivaroxabanIBA 10/2022 - 01/2016
3	LDL CholesterolIBA 01/2022 - 01/2012
3	oxidized low density lipoproteinIBA 01/2022 - 04/2017
2	PCSK9 InhibitorsIBA 03/2024 - 07/2023
2	Proprotein Convertase 9IBA 09/2023 - 10/2022
2	nitinolIBA 12/2020 - 12/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2019 - 05/2011
2	AnticoagulantsIBA 12/2018 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	SubtilisinIBA 03/2024
1	Factor Xa InhibitorsIBA 10/2022
1	N(4)-oleylcytosine arabinosideIBA 10/2022
1	2-bromolysergic acid diethylamide (BOL)IBA 08/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020
1	Irbesartan FDA LinkGeneric 01/2020
1	Vitamin K FDA Link 12/2018
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2017
1	Insulin Glargine (Lantus)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Phenobarbital (Luminal)FDA Link 06/2014
1	polyelectrolyte 60IBA 04/2012
1	HDL CholesterolIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012

14	Therapeutics 10/2023 - 08/2009
8	Stents 03/2024 - 01/2018
6	Catheters 11/2023 - 06/2014
3	Percutaneous Coronary Intervention 10/2022 - 08/2009
1	Thrombectomy 11/2023
1	Sclerotherapy 05/2022
1	Vascular Surgical Procedures 10/2009